Published by Iain Gilbert on 20th September 2022
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Evusheld, its long-acting antibody combination, had been granted approval for the treatment of adults and adolescents with Covid-19 in the European Union.
URL: http://www.digitallook.com/dl/news/story/32972839/...